Newsletter | September 16, 2022

09.16.22 -- How Updated FDA Guidance Impacts Component Selection

USP <382>: Think Systems, Not Components — Fragmentation, Plunger And Tip-Cap/Needle-Shield Functional Suitability Of Syringes And Cartridges

United States Pharmacopeia (USP) requirements for elastomeric components of container closure systems used for parenteral products are changing. Better understand the application of USP <382> prescribed testing to cartridges and syringes, from a mechanical testing perspective.

De-Risking Visible Particles Through Component Selection

The draft guidance “Inspection of Injectable Products for Visible Particulates” is intended to clarify the various areas where controls must be in place for a successful particle control strategy that meets regulatory expectations. This article is a summary of the draft guidance and how it applies to components.

Performance Of Novapure Plungers For Syringes In Autoinjector Systems

Moving from vial systems to prefilled syringes and autoinjector systems requires patient and caregiver needs, drug product requirements, system components, and performance.

Extractables And Leachables: Assessing Risk In A Complex Landscape

It is not surprising that there is still confusion on the extractables and leachables topic. Guidances, where available, do not give step-by-step instructions. And drug products and other drug product contact materials are getting increasingly complex. So, where should you start?

Updated FDA Guidance: Inspection Of Injectable Products For Visible Particulate

Review the details of the draft guidance and the importance of component selection as it relates to establishing a risk-based approach. We examine the role that the NovaPure® product line can play in component selection including the importance of applying an appropriate test method for particle analysis of components.

The Importance Of A Human-Centered Approach To Product Development

To meet the needs of patients, lifesaving device innovations are needed for the next generation of delivery devices. As drug manufacturers explore the device world, human factors are a key consideration.

The Science Behind Containment and Delivery of Injectable Medicines

From trends in self-injection systems and biologic drug delivery to discussions on how to scale up complex medical devices and compliance with governmental regulations and industry guidances, the West Knowledge Center seeks to serve the industry by providing helpful insights and information.


Register today to gain access to all the information the West Knowledge Center provides, including technical reports and bulletins, case studies, scientific posters, and more.


Register here for access to the West Knowledge Center.